Division of Hematology, Japanese Red Cross Society Wakayama Medical Center, Japan.
Division of Pathology, Japanese Red Cross Society Wakayama Medical Center, Japan.
Intern Med. 2021 Aug 15;60(16):2659-2662. doi: 10.2169/internalmedicine.6948-20. Epub 2021 Mar 8.
Histiocytic sarcoma (HS) is an extremely rare non-Langerhans cell disorder with an aggressive course and limited treatment options. HS most often presents at an advanced clinical stage, with a limited response to chemotherapy and high mortality. No standard treatment has been established for HS. We herein describe the first case of HS concomitant with laryngeal carcinoma that was promptly diagnosed and successfully treated; the condition of the patient has remained stable for 4 years with no recurrence.
组织细胞肉瘤(HS)是一种极为罕见的非朗格汉斯细胞疾病,具有侵袭性病程和有限的治疗选择。HS 通常在晚期临床阶段出现,对化疗反应有限,死亡率高。目前尚未为 HS 确立标准治疗方法。我们在此描述首例伴有喉癌的 HS 病例,该病例得到及时诊断和成功治疗;患者的病情在 4 年内保持稳定,无复发。